Literature DB >> 10212627

Homocysteine: an emerging age-related cardiovascular risk factor.

A Moustapha1, K Robinson.   

Abstract

Homocysteine is an intermediate formed during the metabolism of the essential sulfur containing amino acid methionine. Homocysteine concentration rises progressively with age in men and women, making it an important risk factor for cardiovascular disease. The causes are still under study, but likely culprits include clinical or subclinical folate and B vitamin deficiencies and possibly renal dysfunction. The association between adverse cardiovascular events and plasma homocysteine persists in older populations. In women, homocysteine levels increase after menopause and may be related to decreased estrogen concentrations. Folic acid supplementation decreases homocysteine concentration, but coadministration of vitamin B12 may be needed to prevent irreversible neurologic damage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212627

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  2 in total

1.  Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women.

Authors:  R Y Man; L K Ting; S Fan; M M Lau; Y L Siow; Y H Chung; K O
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

2.  Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of β-catenin in response to homocysteine.

Authors:  Richard S Beard; Jason J Reynolds; Shawn E Bearden
Journal:  Vascul Pharmacol       Date:  2012-01-21       Impact factor: 5.773

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.